Evren AE

References (7)

Title : New N-(1,3,4-thiadiazole-2-yl)acetamide derivatives as human carbonic anhydrase I and II and acetylcholinesterase inhibitors - Dawbaa_2024_J.Biomol.Struct.Dyn__1
Author(s) : Dawbaa S , Turkes C , Nuha D , Demir Y , Evren AE , Yurttas L , Beydemir S
Ref : J Biomol Struct Dyn , :1 , 2024
Abstract : Dawbaa_2024_J.Biomol.Struct.Dyn__1
ESTHER : Dawbaa_2024_J.Biomol.Struct.Dyn__1
PubMedSearch : Dawbaa_2024_J.Biomol.Struct.Dyn__1
PubMedID: 38533902

Title : Design and synthesis of phenoxy methyl-oxadiazole compounds against Alzheimer's disease - Evren_2024_Arch.Pharm.(Weinheim)__e2400115
Author(s) : Evren AE , Nuha D , Ozkan BNS , Kahraman C , Gonulalan EM , Yurttas L
Ref : Arch Pharm (Weinheim) , :e2400115 , 2024
Abstract : Evren_2024_Arch.Pharm.(Weinheim)__e2400115
ESTHER : Evren_2024_Arch.Pharm.(Weinheim)__e2400115
PubMedSearch : Evren_2024_Arch.Pharm.(Weinheim)__e2400115
PubMedID: 38657203

Title : Synthesis, characterization, molecular docking and molecular dynamics simulations of novel 2,5-disubstituted-1,3,4-thiadiazole derivatives as potential cholinesterase\/monoamine oxidase dual inhibitors for Alzheimer's disease - Al-Sharabi_2023_J.Biomol.Struct.Dyn__1
Author(s) : Al-Sharabi AA , Evren AE , Saglik BN , Yurttas L
Ref : J Biomol Struct Dyn , :1 , 2023
Abstract : Al-Sharabi_2023_J.Biomol.Struct.Dyn__1
ESTHER : Al-Sharabi_2023_J.Biomol.Struct.Dyn__1
PubMedSearch : Al-Sharabi_2023_J.Biomol.Struct.Dyn__1
PubMedID: 37909464

Title : Design, Synthesis, and In Vitro and In Silico Approaches of Novel Indanone Derivatives as Multifunctional Anti-Alzheimer Agents - Saglik_2022_ACS.Omega_7_47378
Author(s) : Saglik BN , Levent S , Osmaniye D , Evren AE , Karaduman AB , Ozkay Y , Kaplancikli ZA
Ref : ACS Omega , 7 :47378 , 2022
Abstract : Saglik_2022_ACS.Omega_7_47378
ESTHER : Saglik_2022_ACS.Omega_7_47378
PubMedSearch : Saglik_2022_ACS.Omega_7_47378
PubMedID: 36570177

Title : Synthesis, anticholinesterase activity, molecular docking, and molecular dynamic simulation studies of 1,3,4-oxadiazole derivatives - Durmaz_2022_Arch.Pharm.(Weinheim)__e2200294
Author(s) : Durmaz S , Evren AE , Saglik BN , Yurttas L , Tay NF
Ref : Arch Pharm (Weinheim) , :e2200294 , 2022
Abstract : Durmaz_2022_Arch.Pharm.(Weinheim)__e2200294
ESTHER : Durmaz_2022_Arch.Pharm.(Weinheim)__e2200294
PubMedSearch : Durmaz_2022_Arch.Pharm.(Weinheim)__e2200294
PubMedID: 35972839

Title : Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE\/MAO-B dual inhibitors - Osmaniye_2021_Arch.Pharm.(Weinheim)__e2100450
Author(s) : Osmaniye D , Evren AE , Saglik BN , Levent S , Ozkay Y , Kaplancikli ZA
Ref : Arch Pharm (Weinheim) , :e2100450 , 2021
Abstract : Osmaniye_2021_Arch.Pharm.(Weinheim)__e2100450
ESTHER : Osmaniye_2021_Arch.Pharm.(Weinheim)__e2100450
PubMedSearch : Osmaniye_2021_Arch.Pharm.(Weinheim)__e2100450
PubMedID: 34931332

Title : New indane derivatives containing 2-hydrazinothiazole as potential acetylcholinesterase and monoamine oxidase-B inhibitors - Ates_2021_Z.Naturforsch.C.J.Biosci__
Author(s) : Ates I O , Evren AE , Saglik BN , Yurttas L
Ref : Z Naturforsch C J Biosci , : , 2021
Abstract : Ates_2021_Z.Naturforsch.C.J.Biosci__
ESTHER : Ates_2021_Z.Naturforsch.C.J.Biosci__
PubMedSearch : Ates_2021_Z.Naturforsch.C.J.Biosci__
PubMedID: 34047146